Google researchers got an eye-scanning algorithm to figure out on its own how to detect a common form of blindness, showing the potential for artificial intelligence to transform medicine remarkably soon. The algorithm can look at retinal images and detect diabetic retinopathy--which affects almost a third of diabetes patients--as well as a highly trained ophthalmologist can. It makes use of the same machine-learning technique that Google uses to label millions of Web images. Diabetic retinopathy is caused by damage to blood vessels in the eye and results in a gradual deterioration of vision. If caught early it can be treated, but a sufferer may experience no symptoms early on, making screening vital.

Google researchers got an eye-scanning algorithm to figure out on its own how to detect a common form of blindness, showing the potential for artificial intelligence to transform medicine remarkably soon. The algorithm can look at retinal images and detect diabetic retinopathy--which affects almost a third of diabetes patients--as well as a highly trained ophthalmologist can. It makes use of the same machine-learning technique that Google uses to label millions of Web images. Diabetic retinopathy is caused by damage to blood vessels in the eye and results in a gradual deterioration of vision. If caught early it can be treated, but a sufferer may experience no symptoms early on, making screening vital.

Google researchers got an eye-scanning algorithm to figure out on its own how to detect a common form of blindness, showing the potential for artificial intelligence to transform medicine remarkably soon. The algorithm can look at retinal images and detect diabetic retinopathy--which affects almost a third of diabetes patients--as well as a highly trained ophthalmologist can. It makes use of the same machine-learning technique that Google uses to label millions of Web images. Diabetic retinopathy is caused by damage to blood vessels in the eye and results in a gradual deterioration of vision. If caught early it can be treated, but a sufferer may experience no symptoms early on, making screening vital.